Lenvatinib After Progression on Imatinib, Sunitinib, and Regorafenib for GIST Patients
Lenvatinib After Progression on Imatinib, Sunitinib, and Regorafenib for GIST Patients
Recruiting · NCT07096609 · Registry updated 2026-04-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lenvatinib After Progression on Imatinib, Sunitinib, and Regorafenib for GIST Patients | gastrointestinal stromal tumor | Recruiting | Phase 1 / Phase 2 | 2026-04-03 | NCT07096609 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Asan Medical Center | 114 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asan Medical Center | Seoul | South Korea | 338 |